Breaking News Instant updates and real-time market news.

DBVT

DBV Technologies

$23.43

0.63 (2.76%)

10:20
11/20/17
11/20
10:20
11/20/17
10:20

Jefferies still sees better than 50% odds for DBV approval

Jefferies analyst Eun Yang says DBV Technologies' Phase 3 safety data this morning demonstrate "similar, favorable safety" versus the prior Phase 3 trial. The analyst expects DBV to file a Biologics License Application in the first half of 2018 and continues to see greater than 50/50 likelihood for FDA approval. Yang has a Buy rating on the shares with a $37 price target.

DBVT DBV Technologies
$23.43

0.63 (2.76%)

11/20/17
SBSH
11/20/17
NO CHANGE
Target $57
SBSH
Buy
DBV safety study data contained few surprises, says Citi
Citi analyst Liav Abraham says this morning's headline data from DBV Technologies' Phase III Viaskin Peanut safety study yielded few surprises, with the study results "largely confirmatory of the benign safety profile" seen thus far in other clinical trials. The regulatory path forward for Viaskin Peanut with FDA remains unclear, the analyst adds. She believes DBV is likely to receive guidance from the FDA to file a Biologics License Application for Viaskin Peanut based on the totality of the data from the clinical trials thus far, and for a panel to address the approvability of the therapy. Abraham has a Buy rating on the shares with a $57 price target.
11/17/17
JMPS
11/17/17
INITIATION
Target $30
JMPS
Outperform
DBV Technologies resumed with an Outperform at JMP Securities
JMP Securities analyst Liisa A. Bayko resumed coverage of DBV Technologies with an Outperform rating and $30 price target, stating that since the release of PEPITES data she has engaged with regulatory experts and doctors to assess the chances for approval and any changes in the intent to treat with Viaskin Peanut. Following the work, Bayko still thinks there is a path to approval and assigns a 60% probability of success for Viaskin Peanut. She also noted that her survey work pointed to no material change to anticipated adoption.
10/31/17
SOCG
10/31/17
UPGRADE
SOCG
Hold
DBV Technologies upgraded to Hold from Sell at Societe Generale
10/26/17
JEFF
10/26/17
NO CHANGE
Target $37
JEFF
Buy
Jefferies poll shows allergists view DBV data as clinically meaningful
Jefferies analyst Eun Yang says her firm's poll of 25 U.S. allergists shows a majority, or 92%, view DBV Technologies' Phase 3 data for Viaskin Peanut as clinically meaningful and 80% think the treatment should get FDA approval. The potential utilization of Viaskin Peanut, if approved, is down from her firm's prior survey, however, to 30%-35% of kids with peanut allergy versus 50% prior. Yang keeps a Buy rating on DBV and believes Viaskin Peanut has a greater than 50% chance of FDA approval. Her price target for the shares is $37.

TODAY'S FREE FLY STORIES

WEN

Wendy's

$15.63

0.24 (1.56%)

, MCD

McDonald's

$173.35

-0.2 (-0.12%)

15:41
12/14/17
12/14
15:41
12/14/17
15:41
Hot Stocks
Chanos says he'd short almost all fast food stocks, except McDonald's »

While being interviewed…

WEN

Wendy's

$15.63

0.24 (1.56%)

MCD

McDonald's

$173.35

-0.2 (-0.12%)

QSR

Restaurant Brands

$61.49

0.16 (0.26%)

YUM

Yum! Brands

$82.12

-0.07 (-0.09%)

JACK

Jack in the Box

$102.49

-0.09 (-0.09%)

SONC

Sonic

$28.32

0.38 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

SLM

Sallie Mae

$11.16

-0.45 (-3.88%)

15:40
12/14/17
12/14
15:40
12/14/17
15:40
Options
Sallie Mae sees notable call buying »

Sallie Mae sees notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$39.53

0.24 (0.61%)

, PRGO

Perrigo

$82.91

-3.11 (-3.62%)

15:36
12/14/17
12/14
15:36
12/14/17
15:36
Periodicals
Mylan, Perrigo among those interesed in Merck KGaA unit, Bloomberg says »

Mylan (MYL), Perrigo…

MYL

Mylan

$39.53

0.24 (0.61%)

PRGO

Perrigo

$82.91

-3.11 (-3.62%)

MKGAY

Merck KGaA

RBGLY

Reckitt Benckiser

$18.17

0.11 (0.61%)

NSRGY

Nestle

$86.67

0.61 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$26.16

0.62 (2.43%)

15:34
12/14/17
12/14
15:34
12/14/17
15:34
Periodicals
Airbus COO expected to step down, Reuters reports »

Airbus COO and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil Circuit

$27.56

-0.99 (-3.47%)

15:34
12/14/17
12/14
15:34
12/14/17
15:34
Options
Jabil Circuit options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 09

    Jan

MCD

McDonald's

$173.34

-0.21 (-0.12%)

, QSR

Restaurant Brands

$61.42

0.09 (0.15%)

15:32
12/14/17
12/14
15:32
12/14/17
15:32
Hot Stocks
Jim Chanos says not short McDonald's, but is short other fast food stocks »

Chanos, in making…

MCD

McDonald's

$173.34

-0.21 (-0.12%)

QSR

Restaurant Brands

$61.42

0.09 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$10.30

-0.66 (-6.02%)

15:30
12/14/17
12/14
15:30
12/14/17
15:30
Options
Express calls active as shares see relative weakness »

Express calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

, DIS

Disney

$111.17

3.555 (3.30%)

15:29
12/14/17
12/14
15:29
12/14/17
15:29
Recommendations
21st Century Fox, Disney analyst commentary  »

21st Century Fox should…

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

DIS

Disney

$111.17

3.555 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

TSLA

Tesla

$339.03

-2 (-0.59%)

15:28
12/14/17
12/14
15:28
12/14/17
15:28
Hot Stocks
Tesla 'already behind' on vehicle autonomy, Chanos says »

Jim Chanos of Kynikos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

TSLA

Tesla

$339.03

-2 (-0.59%)

15:27
12/14/17
12/14
15:27
12/14/17
15:27
Hot Stocks
Chanos says Tesla CEO Musk 'has broad interpretation of truth' »

Jim Chanos, who is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

BTC

Bitcoin

, BITCOIN

Bitcoin

15:19
12/14/17
12/14
15:19
12/14/17
15:19
General news
Chanos says 'not short' bitcoin but 'speculation' in it indicative of market »

Jim Chanos of Kynikos…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$176.83

4.29 (2.49%)

15:19
12/14/17
12/14
15:19
12/14/17
15:19
Options
Adobe options imply 6.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EADSY

Airbus

$26.16

0.62 (2.43%)

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Periodicals
Breaking Periodicals news story on Airbus »

Airbus CEO intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

, ESRX

Express Scripts

$68.57

0.01 (0.01%)

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Periodicals
Chanos says tax bill will affect healthcare more than people think »

Chanos mentioned…

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

ESRX

Express Scripts

$68.57

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

$NYE

NYSE Market Internals

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

15:12
12/14/17
12/14
15:12
12/14/17
15:12
Periodicals
Speaker Ryan says not leaving Congress anytime soon, CBS News reports »

Following a media report…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$2.93

-0.095 (-3.15%)

15:10
12/14/17
12/14
15:10
12/14/17
15:10
Options
Bulls and bears in JC Penney Thursday »

Bulls and bears in JC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

, CMCSK

Comcast

15:06
12/14/17
12/14
15:06
12/14/17
15:06
Periodicals
Comcast offered more for Fox assets, but Fox preffered Disney deal, CNBC says »

Sources tell CNBC's…

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

CMCSK

Comcast

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

COST

Costco

$188.28

-0.02 (-0.01%)

15:04
12/14/17
12/14
15:04
12/14/17
15:04
Options
Costco options imply 5.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VRX

Valeant

$19.22

-2.83 (-12.83%)

15:03
12/14/17
12/14
15:03
12/14/17
15:03
Technical Analysis
Technical View: Valeant near session lows, levels to watch »

The shares are bouncing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 27

    Dec

  • 18

    Jun

CI

Cigna

$204.17

-3.75 (-1.80%)

15:02
12/14/17
12/14
15:02
12/14/17
15:02
Hot Stocks
Cigna announces acquisition of digital health plan platform Brighter »

Cigna announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
12/14/17
12/14
15:00
12/14/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

ORCL

Oracle

$50.25

0.195 (0.39%)

14:49
12/14/17
12/14
14:49
12/14/17
14:49
Options
Oracle options imply 7.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DIS

Disney

$111.04

3.43 (3.19%)

, FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

14:44
12/14/17
12/14
14:44
12/14/17
14:44
Recommendations
Disney, 21st Century Fox analyst commentary  »

RBC Capital sees Disney,…

DIS

Disney

$111.04

3.43 (3.19%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.